Importantly, HT1 pigs develop HCC in a fibrosis-dependent manner like humans and unlike mice37,60,61, which makes the FAH-deficient pig an ideal preclinical model to approximate the potential deleterious effects of lentiviral therapy and NTBC treatment/withdrawal in humans. The gene discussed is FAH; the disease is hepatocellular carcinoma.